The role of a center for tobacco-dependent in cardiovascular prevention. A retrospective study

Neuroendocrinology Letters

Volumn 33, Issue SUPPL. 2, 2012, Pages 102-107

  Zvolska, Kamila ^a   Kralikova, Eva ^a   Kmetova, Alexandra ^a   Stepankova, Lenka ^a   Blaha, Milan ^b   Sticha, Michal ^b   Bortlicek, Zbynek ^b   Ceska, Richard ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Cardiovascular diseases; Early medical intervention; Nicotine dependence; Risk factors; Smoking cessation

Indexed keywords

CARBON MONOXIDE;

ADULT; BLOOD PRESSURE; BLOOD SAMPLING; BODY WEIGHT; CARDIOVASCULAR RISK; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; RETROSPECTIVE STUDY; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT DURATION;

EID: 84871038560     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Beck AT (2006). Depression: Causes and Treatment. Philadelphia: University of Pennsylvania Press. ISBN 0-8122-1032-8.
2. Conroy R, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al (2003). Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 24: 87-1003.
3. Critchley JA, Capewell S (2003). Mortality risk reduction associated with coronary heart disease: a systematic review. JAMA. 290: 86-97. (Pubitemid 37432870)
4. Dochi M, Sakata K, Oishi M, Tanaka K, Kobayashi E, Suwazono Y (2009). Smoking as an independent risk factor for hypertension: a 14-year longitudinal study in male Japanese workers. Tohoku J Exp Med. 217: 37-43.
5. Doll R, Peto R, Boreham J, Sutherland I (2004). Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 328: 1519.
6. Fagerström K (2012). Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res. 14: 75-78.
7. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al (2008) Treating tobacco use and dependence: 2008 Update - clinical practice guidelines. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, 208, Agency for Healthcare Research and Quality.
8. Gaemperli O, Liga R, Bhamra-Ariza P, Rimoldi O (2010). Nicotine addiction and coronary artery disease: impact of cessation interventions. Curr Pharm Des. 16: 2586-2597.
9. Gordon T, Kannel WB, Dawber TR, MGee D (1975). Changes associated with quitting cigarette smoking: the Framingham Study. Am Heart J. 90: 322-328.
10. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al (2007). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur J Cardiovasc Prev Rehabil. 14 Suppl 2: S1-S113.
11. Greene SB, Aavedal MJ, Tyroler HA, Davis CE, Hames CG (1977). Smoking habits and blood pressure change: a seven year follow-up. J Chron Dis. 30: 401-413. (Pubitemid 8154984)
12. Green MS, Hrari G (1995). A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men: the Israeli Cordis Study. J Clin Epidemiol. 48: 1159-1166.
13. Humphries SE, Talmud PJ, Hawe E, Bolla M, Day IN, Miller GJ (2001). Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet. 358: 115-119. (Pubitemid 32709850)
14. Killen JD, Taylor CB, Hayward C, Wilson DM, Haydel KF, Hammer LD, et al (1994). Pursuit of thinness and onset of eating disorder symptoms in a community sample of adolescent girls: a three-year prospective analysis. Int J Eat Dis. 16: 227-238. (Pubitemid 24331232)
15. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U (2009). EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from twenty two European countries. EUROASPIRE Study Group. Europ J Cardiovasc Prev Rehabilitation. 16: 121-137.
16. Kralikova E, Kmetova A, Stepankova L, Zvolska K, Felbrova V, Kulovana S et al (2012). Czech medical community: education and treatment of tobacco dependence 2012. XIV Annual Meeting of the SRNT Europe. Aug 30-Sep 3, 2012; Helsinki, Finland. Abstract book, p 72.
17. Lakier JB (1992). Smoking and Cardiovascular Disease. Am J Med. 93: S8-S12.
18. Lee DH, Ha MH, Kim JR, Jacobs DR (2001). Effects of Smoking Cessation on Changes in Blood Pressure and Incidence of Hypertension. A 4-Year Follow-Up Study. Hypertension. 37: 194-198.
19. Monsó E, Campbell J, Tønnesen P, Gustavsson G, Morera J (2001). Sociodemographic predictors of success in smoking intervention. Tob Control. 10: 165-169. (Pubitemid 33720581)
20. Parsons AC, Shraim M, Inglis J, Aveyard P, Hajek P (2009). Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev.
21. Reiner Z, Catapano AL, Guy De Backer, Graham I, Taskinen MR, Wiklund O, et al (2011). ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 32: 1769-1818.
22. Stranska Z, Matoulek M, Vilikus Z, Svacina S, Stransky P (2011). Aerobic exercise has beneficial impact on atherogenic index of plasma in sedentary overweigh and obese women. Neuroendocrinol Lett. 32: 1-109.
23. Tonstad S, Svendsen M (2005). Premature coronary heart disease, cigarette smoking, and the metabolit syndrome. Am J Cardiol. 96: 1681-1685. (Pubitemid 41790391)
24. Wannamethee SG, Shaper AG, Perry IJ (2001). Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 24: 1590-1595.
25. Wilkes S, Evans A (1999). A cross-sectional study comparing the motivation for smoking cessation in apparently healthy patients who smoke to those who smoke and have ischaemic heart disease, hypertension or diabetes. Fam Pract. 16: 608-610. (Pubitemid 30000178)
26. Willigendael EM, Teijink JA, Bartelink ML, Kuiken BW, Boiten J, Moll FL, et al (2004). Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg. 40: 1158-1165. (Pubitemid 40037284)